Bowel Dysfunction Related to Spina Bifida: Keep It Simple.

Dis Colon Rectum

1 Service des Maladies de l'Appareil Digestif, Centre Hospitalier Universitaire Pontchaillou, Université de Rennes 1, Rennes, France 2 Service d'Explorations Fonctionnelles Digestives, Centre Hospitalier Universitaire Pontchaillou, Université de Rennes 1, Rennes, France 3 Institut National de la Santé et de la Recherche Médicale U1235, Université de Nantes, Nantes, France 4 Centre d'Investigation Clinique 1414, Inflammation and Physiology, Université de Rennes 1, Rennes, France 5 Service d'Urologie, Centre Hospitalier Universitaire Pontchaillou, Rennes, France 6 Centre Référence National Maladies Rares Spina Bifida, Centre Hospitalier Universitaire Pontchaillou, Rennes, France 7 Institut National de la Santé et de la Recherche Médicale U991, Université de Rennes, Rennes, France.

Published: November 2017

Background: Although care of urological disorders in spina bifida is well established, there is yet no agreement on a standardized approach to bowel dysfunction in this population.

Objective: The purpose of this study was to assess bowel dysfunction using validated instruments and the risk factors in adults with spina bifida.

Design: A multidisciplinary team prospectively collected patient data, focusing on anorectal and urological symptoms.

Settings: The study was conducted with data from a French referral center for spina bifida.

Patients: A total of 228 adults with spina bifida (sex ratio men:women, 92 (40%):136 (60%)) with a median age of 34.7 years (range, 26.8-44.7 y) were assessed.

Main Outcomes Measures: Factors associated with severe fecal incontinence (Cleveland Clinic Incontinence Score ≥9) and severe bowel dysfunction (Neurogenic Bowel Dysfunction score ≥14) were assessed in a multivariate analysis model.

Results: The prevalence rates of severe fecal incontinence and severe bowel dysfunction were 60% (130/217) and 42% (71/168). Bowel dysfunction was the second most common major concern of patients after lower urinary tract dysfunction. Male sex, obesity, urinary incontinence, and a Knowles-Eccersley-Scott symptom constipation score ≥10 were independently associated with severe fecal incontinence. Patients with soft stools had significantly less severe bowel dysfunction. Neither neurologic level nor other neurologic features of spina bifida were associated with severe fecal incontinence or severe bowel dysfunction.

Limitations: The recruitment of patients with spina bifida through a national referral center might have resulted in selection bias, and some data were missing especially regarding BMI and Neurogenic Bowel Dysfunction score (21% and 26% of missing data).

Conclusions: The prevalence rates of severe fecal incontinence and severe bowel dysfunction in adults with spina bifida were high and were adequately perceived by the patients. The present study emphasized the association of bowel dysfunction and fecal incontinence with obesity, urologic disorders, and stool consistency rather than neurologic features. See Video Abstract at http://links.lww.com/DCR/A394.

Download full-text PDF

Source
http://dx.doi.org/10.1097/DCR.0000000000000892DOI Listing

Publication Analysis

Top Keywords

bowel dysfunction
44
spina bifida
24
fecal incontinence
24
severe fecal
20
severe bowel
20
bowel
12
adults spina
12
associated severe
12
incontinence severe
12
dysfunction
11

Similar Publications

Intestinal protozoan infections among schoolchildren in China.

Infection

January 2025

National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, Chinese Center for Tropical Diseases Research, National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, NHC Key Laboratory of Parasite and Vector Biology, WHO Collaborating Centre for Tropical Diseases, National Center for International Research on Tropical Diseases, Ministry of Science and Technology, Shanghai, China.

View Article and Find Full Text PDF

Role of the gut microbiome in psychological symptoms associated with inflammatory bowel diseases.

Semin Immunopathol

January 2025

Department of Medicine II, Medical Faculty Mannheim, University Medical Center Mannheim, Heidelberg University, Mannheim, Germany.

The brain-gut axis constitutes the basis for the bidirectional communication between the central nervous system and the gastrointestinal tract driven by neural, hormonal, metabolic, immunological, and microbial signals. Alterations in the gut microbiome composition as observed in inflammatory bowel diseases can modulate brain function and emerging empirical evidence has indicated that interactions among the brain-gut microbiome-axis seem to play a significant role in the pathogenesis of both inflammatory bowel diseases and psychiatric disorders and their comorbidity. Yet, the immunological and molecular mechanisms underlying the co-occurrence of inflammatory bowel diseases and psychological symptoms are still poorly understood.

View Article and Find Full Text PDF

[The intestinal microbiota in inflammatory bowel diseases].

Inn Med (Heidelb)

January 2025

Lehrstuhl für Ernährung und Immunologie, School of Life Sciences, Technische Universität München, Gregor-Mendel-Straße 2, 85354, Freising, Deutschland.

Background: The intestinal microbiota comprises all living microorganisms in the gastrointestinal tract and is crucial for its function. Clinical observations and laboratory findings confirm a central role of the microbiota in chronic inflammatory bowel diseases (IBD). However, many mechanistic details remain unclear.

View Article and Find Full Text PDF

Crohn's disease (CD) is a chronic inflammatory bowel disease with an unknown etiology. Ubiquitination plays a significant role in the pathogenesis of CD. This study aimed to explore the functional roles of ubiquitination-related genes in CD.

View Article and Find Full Text PDF

Objectives: To assess the therapeutic effects and safety of Tongxie Yaofang (TXYF) granules vs placebo as an alternative treatment for diarrhoea-predominant irritable bowel syndrome (IBS-D). We hypothesised that TXYF would improve clinical responses among patients with IBS-D.

Design: A randomised, double-blind, placebo-controlled, phase II, superiority trial.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!